<DOC>
	<DOCNO>NCT00381043</DOCNO>
	<brief_summary>This study medication , acamprosate , FDA approve medication alcohol problem . We examine whether acamprosate compare sugar pill ( placebo ) effective help drink Family Medicine clinic .</brief_summary>
	<brief_title>Study Campral ( Acamprosate ) Alcohol Dependence Family Medicine Clinic</brief_title>
	<detailed_description>Acamprosate show reduce drink day alcohol dependent patient promote abstinence , report side effect . A limitation study , however , lack generalizability due restrictive inclusion exclusion criterion . Furthermore , previous study acamprosate conduct Europe , different treatment set typical American Family Medicine center , alcohol dependent patient likely first identify U.S . The present study design determine efficacy acamprosatefor alcohol dependence Family Medicine set use minimal psychotherapeutic interventionsâ€”as would also likely occur primary care set . The study 12-week , double-blind , placebo-controlled , randomized trial compare 666 mg acamprosate t.i.d . placebo patient UNC Family Medicine Center alcohol dependence . Subjects see Family Medicine physician receive brief motivational intervention . Primary efficacy determine measure % day abstinent secondary outcome include rate complete abstinence , % heavy drinking day , CGI GGT acamprosate group compare placebo group .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Men woman age 21 65 year diagnosis alcohol dependence . 2 . History least 2 heavy drinking day ( men &gt; 5 drinks/day ; woman &gt; 4 drinks/day ) per week , average , month prior screen . 3 . Ability understand sign write informed consent . 4 . Willingness refrain drinking least three day prior randomization . 5 . Willingness consider goal abstinence significant reduction drink objective . EXCLUSION CRITERIA : 1 . Clinically significant medical disease might interfere evaluation study medication present safety concern . 2 . Clinically significant psychiatric disease , e.g . bipolar disorder , psychosis , might interfere study participation present safety concern . [ Subjects depression anxiety disorder receive medication clinically stable least one month exclude . ] 3 . Suicidal ideation behavior , history suicide attempt . 4 . Renal Impairment ; estimate creatinine clearance &lt; 50 ml/min . 5 . Substance use disorder alcohol nicotine dependence cannabis abuse . 6 . Pregnant breastfeed woman woman childbearing potential practice medically acceptable form birth control ( oral depot contraceptive , barrier method diaphragm condom spermicidal ) . 7 . Individuals require inpatient treatment intense outpatient treatment alcohol dependence . Individuals may consider trial upon completion medical detoxification .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Family Medicine Setting</keyword>
	<keyword>University North Carolina Chapel Hill</keyword>
</DOC>